The global lacrimal devices market size was US$ 143.71 million in 2021. The global lacrimal devices market size is forecast to reach US$ 221 million by 2030, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period from 2022 to 2030.
The lacrimal system is an ocular defense mechanism that keeps the eye moist and dust-free. The nasal punctum and lacrimal ducts of the eye are typically the only lacrimal organs. The lacrimal devices' main function is to fix the lacrimal drainage system. During a nasal punctum procedure, a silicone balloon or catheter is placed into the punctum. The balloon is then put into the lacrimal duct to maintain the integrity of the nasolacrimal duct and enable tear fluid outflow from the eye.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had severely affected the ophthalmology service and ophthalmic practice. In 2020, many businesses saw a slowdown in product output and substantial difficulties exporting goods. As a result of delays or cancellations of non-essential surgical, minimally invasive operations and an increase in COVID-19 infections owing to lockdown. For instance, the American College of Surgeons recommended delaying non-emergency surgical treatments such as endoscopic dacryocystorhinostomy, lacrimal surgery, and cataract surgery.
Regional Analysis
North America garnered a substantial market share in 2021 and is forecast to remain dominant during the forecast period. As a result of the region's increased approval rate of lacrimal equipment, well-established healthcare sector, and rising incidence of eye diseases. In addition, adequate surgical device rules and rising public awareness of the necessity for such procedures in cases of lacrimal duct obstruction. Furthermore, the increasing elderly population citizenry and the existence of major players. Thus, these factors drive the market growth in the region.
Leading Competitors
The leading prominent companies profiled in the global lacrimal devices market are:
Scope of the Report
The global lacrimal devices market segmentation focuses on Product, Application, End-Use, and Region.
Segmentation based on Product
Segmentation based on Application
Segmentation based on End-Use
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL LACRIMAL DEVICES MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL LACRIMAL DEVICES MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL LACRIMAL DEVICES MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 STENTS
5.3 INTUBATION SETS
5.4 TUBES
5.5 DILATOR
5.6 CANNULA & SPATULA
5.7 PUNCTAL PLUGS
5.8 OTHERS
6 GLOBAL LACRIMAL DEVICES MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 DRY EYE
6.3 DRAINAGE OBSTRUCTION
6.4 GLAUCOMA
6.5 LACRIMAL GLAND INFLAMMATION
6.6 EPIPHORA
6.7 OTHERS
7 GLOBAL LACRIMAL DEVICES MARKET, BY END-USE
7.1 OVERVIEW
7.2 HOSPITALS
7.3 DIAGNOSTIC CENTERS
7.4 OPHTHALMIC CLINICS
7.5 OTHERS
8 GLOBAL LACRIMAL DEVICES MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL LACRIMAL DEVICES MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 BVI MEDICAL
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 BESS MEDICAL TECHNOLOGY GMBH
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 FCI OPHTHALMIC
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 AUROLAB
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 GUNTHER WEISS SCIENTIFIC
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 KANEKA CORPORATION
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 LACRIMEDICS
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8 RUMEX INTERNATIONAL
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 COOK MEDICAL LLC
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.10 SINOPSYS SURGICAL, INCORPORATED
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved